FDA Documents of Actavis Totowa LLC
Actavis Totowa LLC is an organization that has been audited by the FDA 28 times between 2000 and 2010 across all 3 sites.
Documents
FDA 483 Actavis Totowa LLC, Little Falls | 2009
Out-of-stock
Issued on: Mar 31, 2009
Human Drug Form 483
FDA 483 Actavis Totowa LLC, Elizabeth | 2009
Out-of-stock
Issued on: Mar 31, 2009
Human Drug Form 483
FDA 483 Actavis Totowa LLC, Totowa | 2009
Out-of-stock
Issued on: Mar 31, 2009
Human Drug Form 483
FDA 483 Actavis Totowa LLC, Little Falls | 2008
Out-of-stock
Issued on: May 20, 2008
Human Drug Form 483
FDA 483 Actavis Totowa LLC, Little Falls | 2007
Out-of-stock
Issued on: Sep 28, 2007
Human Drug Form 483
FDA 483 Actavis Totowa LLC, Totowa | 2006
Out-of-stock
Issued on: Oct 11, 2006
Human Drug Form 483
FDA 483 Actavis Totowa LLC, Little Falls | 2006
Out-of-stock
Issued on: Aug 10, 2006
Human Drug Form 483
FDA 483 Actavis Totowa LLC, Little Falls | 2006
Out-of-stock
Issued on: Feb 8, 2006
Human Drug Form 483
FDA 483 Actavis Totowa LLC, Little Falls | 2004
Out-of-stock
Issued on: Dec 1, 2004
Human Drug Form 483
FDA 483 Actavis Totowa LLC, Little Falls | 2003
Out-of-stock
Issued on: Aug 21, 2003
Human Drug Form 483
FDA 483 Actavis Totowa LLC, Totowa | 2003
Out-of-stock
Issued on: Apr 25, 2003
Human Drug Form 483
FDA 483 Actavis Totowa LLC, Little Falls | 2003
Out-of-stock
Issued on: Apr 25, 2003
Human Drug Form 483
FDA 483 Actavis Totowa LLC, Little Falls | 2001
Out-of-stock
Issued on: Nov 29, 2001
Human Drug Form 483
FDA 483 Actavis Totowa LLC, Little Falls | 2000
Out-of-stock
Issued on: May 23, 2000
Human Drug Form 483
FDA Investigators(15)
- Douglas C. Kovacs, FDA Investigator
- Michael R. Klapal, FDA Investigator
- Erin D. McCaffery, FDA Investigator
- Atul Agrawal, FDA Investigator
- William J. Muszynski, FDA Investigator
- Hitesh R. Patel, FDA Investigator
- Kristy A. Zielny, FDA Investigator
- Nancy L. Rolli, FDA Investigator
- Tara G. Bizjak, FDA Investigator
- Karen E. Dorazio, FDA Investigator
- Daniel J. Grabicki, FDA Investigator
- Keith M. Reilly, FDA Investigator
- Barbara J. Maulfair, FDA Investigator
- Paul L. Bellamy, FDA Investigator
- Matthew A. Spataro, FDA Investigator